David M. Johnson

2.8k total citations
88 papers, 2.1k citations indexed

About

David M. Johnson is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, David M. Johnson has authored 88 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pharmacology, 26 papers in Molecular Medicine and 20 papers in Infectious Diseases. Recurrent topics in David M. Johnson's work include Antibiotic Resistance in Bacteria (26 papers), Antibiotics Pharmacokinetics and Efficacy (26 papers) and Chronic Lymphocytic Leukemia Research (17 papers). David M. Johnson is often cited by papers focused on Antibiotic Resistance in Bacteria (26 papers), Antibiotics Pharmacokinetics and Efficacy (26 papers) and Chronic Lymphocytic Leukemia Research (17 papers). David M. Johnson collaborates with scholars based in United States, United Kingdom and Spain. David M. Johnson's co-authors include Ronald N. Jones, M E Erwin, John R. Platt, Douglas J. Biedenbach, Paul F. Goetinck, Hélio S. Sader, Qian Chen, Sean P. Cumming, Dominik R. Haudenschild and Ian W. Flinn and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David M. Johnson

86 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David M. Johnson United States 27 552 420 401 400 393 88 2.1k
Louis W. Heck United States 28 135 0.2× 136 0.3× 594 1.5× 224 0.6× 151 0.4× 65 2.6k
Martin Thurnher Austria 40 47 0.1× 122 0.3× 1.5k 3.7× 212 0.5× 612 1.6× 136 5.0k
Melvin Berger United States 40 588 1.1× 208 0.5× 1.4k 3.4× 86 0.2× 669 1.7× 95 5.5k
Pascale Hubert Belgium 36 197 0.4× 98 0.2× 1.1k 2.6× 53 0.1× 791 2.0× 101 3.6k
Donna M. Williams United States 30 672 1.2× 19 0.0× 1.3k 3.3× 41 0.1× 164 0.4× 98 2.6k
Michael Rodriguez United States 24 90 0.2× 105 0.3× 345 0.9× 218 0.5× 499 1.3× 90 2.2k
Vladimir Lazarević Sweden 23 277 0.5× 77 0.2× 990 2.5× 45 0.1× 91 0.2× 86 2.1k
Luis A. Clavell United States 28 198 0.4× 314 0.7× 482 1.2× 25 0.1× 210 0.5× 61 3.9k
Kenneth M. Kaye United States 30 52 0.1× 1.2k 2.9× 919 2.3× 86 0.2× 2.0k 5.2× 73 4.8k
Danièle Saverino Italy 22 46 0.1× 65 0.2× 153 0.4× 82 0.2× 241 0.6× 77 1.5k

Countries citing papers authored by David M. Johnson

Since Specialization
Citations

This map shows the geographic impact of David M. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Johnson more than expected).

Fields of papers citing papers by David M. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Johnson. The network helps show where David M. Johnson may publish in the future.

Co-authorship network of co-authors of David M. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Johnson. A scholar is included among the top collaborators of David M. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Johnson. David M. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Daniel D., et al.. (2025). Inter-Day Reliability of Countermovement Jump Metrics in Elite Academy Soccer Players. SHILAP Revista de lepidopterología. 5(1).
2.
Sullivan, Joseph, Simon J. Roberts, Kevin Enright, et al.. (2024). Consensus on maturity-related injury risks and prevention in youth soccer: A Delphi study. PLoS ONE. 19(11). e0312568–e0312568.
3.
Bradley, Ben, David M. Johnson, Megan Hill, et al.. (2019). Bio-banding in academy football: player’s perceptions of a maturity matched tournament. Annals of Human Biology. 46(5). 400–408. 71 indexed citations
4.
Johnson, David M.. (2014). Male Reproductive Health Project 2009-2013: Program Implementation, Research Results and Implications for STD Service Delivery. 2 indexed citations
5.
Bernengo, M.G., F. Vanaclocha, Madeleine Duvic, et al.. (2008). A Phase Ii International, Multicenter Study of Oral Panobinostat (lbh589) in Patients With Refractory Cutaneous T-cell Lymphoma (ctcl). DIAL (Catholic University of Leuven). 93. 109. 1 indexed citations
6.
Jones, Ronald N., Douglas J. Biedenbach, David M. Johnson, & Michael A. Pfaller. (2001). In VitroEvaluation of BI 397, a Novel Glycopeptide Antimicrobial Agent. Journal of Chemotherapy. 13(3). 244–254. 50 indexed citations
7.
Jones, Ronald N., Douglas J. Biedenbach, & David M. Johnson. (2000). Cefditoren activity against nearly 1000 non-fastidious bacterial isolates and the development of in vitro susceptibility test methods. Diagnostic Microbiology and Infectious Disease. 37(2). 143–146. 18 indexed citations
8.
Chen, Qian, Yue Zhang, David M. Johnson, & Paul F. Goetinck. (1999). Assembly of a Novel Cartilage Matrix Protein Filamentous Network: Molecular Basis of Differential Requirement of von Willebrand Factor A Domains. Molecular Biology of the Cell. 10(7). 2149–2162. 58 indexed citations
9.
Johnson, David M., Douglas J. Biedenbach, & Ronald N. Jones. (1999). In vitro evaluation of broad-spectrum β-lactams in the Philippines medical centers: role of fourth-generation cephalosporins. Diagnostic Microbiology and Infectious Disease. 35(4). 291–297. 10 indexed citations
10.
Biedenbach, Douglas J., David M. Johnson, & Ronald N. Jones. (1999). In vitro evaluation of cefepime and other broad-spectrum β-lactams in Taiwan medical centers. Diagnostic Microbiology and Infectious Disease. 35(4). 299–305. 10 indexed citations
11.
Ballow, Charles H., et al.. (1997). Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. Diagnostic Microbiology and Infectious Disease. 29(3). 173–186. 30 indexed citations
12.
Johnson, David M., et al.. (1996). Children and HIV : supporting children and their families. OpenGrey (Institut de l'Information Scientifique et Technique). 5 indexed citations
13.
Flynn, Christopher, David M. Johnson, & Ronald N. Jones. (1996). In VitroEfficacy of Levofloxacin Alone or in Combination Tested Against Multi-ResistantPseudomonas aeruginosaStrains. Journal of Chemotherapy. 8(6). 411–415. 18 indexed citations
14.
Johnson, David M. & Ronald N. Jones. (1996). Two investigational glycylcyclines, DMG-DMDOT and DMG-MINO antimicrobial activity studied against gram-positive species. Diagnostic Microbiology and Infectious Disease. 24(1). 53–57. 5 indexed citations
15.
16.
17.
Chen, Qian, David M. Johnson, Dominik R. Haudenschild, & Paul F. Goetinck. (1995). Progression and Recapitulation of the Chondrocyte Differentiation Program: Cartilage Matrix Protein Is a Marker for Cartilage Maturation. Developmental Biology. 172(1). 293–306. 98 indexed citations
18.
Johnson, David M., Ronald N. Jones, & Meridith E. Erwin. (1993). In vitro antimicrobial activity of CP-99433 compared with other fluoroquinolones. Diagnostic Microbiology and Infectious Disease. 17(1). 79–83. 3 indexed citations
19.
Johnson, David M. & Ronald N. Jones. (1992). Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218. European Journal of Clinical Microbiology & Infectious Diseases. 11(2). 181–188. 6 indexed citations
20.
Barrett, Mary S., et al.. (1991). Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628. Diagnostic Microbiology and Infectious Disease. 14(5). 389–401. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louis W. Heck Breakdown of academic impact, for papers by Martin Thurnher Breakdown of academic impact, for papers by Melvin Berger Breakdown of academic impact, for papers by Pascale Hubert Breakdown of academic impact, for papers by Donna M. Williams Breakdown of academic impact, for papers by Michael Rodriguez Breakdown of academic impact, for papers by Vladimir Lazarević Breakdown of academic impact, for papers by Luis A. Clavell Breakdown of academic impact, for papers by Kenneth M. Kaye Breakdown of academic impact, for papers by Danièle Saverino
Rankless by CCL
2026